Aszimmetrikus dimetilarginin: A cardiovascularis betegségek prediktora?

Translated title of the contribution: Asymmetric dimethylarginine: Predictor of cardiovascular diseases?

Németh Balázs, Kustán Péter, Németh Ádám, Lenkey Zsófia, Cziráki Attila, Kiss István, E. Sulyok, Ajtay Zénó

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Cardiovascular diseases are the most common diseases worldwide. They are responsible for one third of global deaths and they are the leading cause of disability, too. The usage of different levels of prevention in combination with effective risk assessment improved these statistical data. Risk assessment based on classic risk factors has recently been supported with several new markers, such as asymmetric dimethylarginine, which is an endogenous competitive inhibitor of nitric oxide synthase. Elevated levels of asymmetric dimethylarginine have been reported in obese, smoker, hypercholesterolemic, hypertensive and diabetic patients. According to previous studies, asymmetric dimethylarginine is a suitable indicator of endothelial dysfunction, which is held to be the previous state of atherosclerosis. Several researches found positive correlation between higher levels of asymmetric dimethylarginine and coronary artery disease onset, or progression of existing coronary disease. According to a study involving 3000 patients, asymmetric dimethylarginine is an independent risk factor of cardiovascular mortality in patients with coronary artery disease. This article summarizes the role of asymmetric dimethylarginine in prediction of cardiovascular diseases, and underlines its importance in cardiovascular prevention.

Original languageHungarian
Pages (from-to)483-487
Number of pages5
JournalOrvosi Hetilap
Volume157
Issue number13
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Cardiovascular Diseases
Coronary Artery Disease
Nitric Oxide Synthase
Coronary Disease
N,N-dimethylarginine
Cause of Death
Atherosclerosis
Mortality
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Balázs, N., Péter, K., Ádám, N., Zsófia, L., Attila, C., István, K., ... Zénó, A. (2016). Aszimmetrikus dimetilarginin: A cardiovascularis betegségek prediktora? Orvosi Hetilap, 157(13), 483-487. https://doi.org/10.1556/650.2016.30396

Aszimmetrikus dimetilarginin : A cardiovascularis betegségek prediktora? / Balázs, Németh; Péter, Kustán; Ádám, Németh; Zsófia, Lenkey; Attila, Cziráki; István, Kiss; Sulyok, E.; Zénó, Ajtay.

In: Orvosi Hetilap, Vol. 157, No. 13, 01.03.2016, p. 483-487.

Research output: Contribution to journalArticle

Balázs, N, Péter, K, Ádám, N, Zsófia, L, Attila, C, István, K, Sulyok, E & Zénó, A 2016, 'Aszimmetrikus dimetilarginin: A cardiovascularis betegségek prediktora?', Orvosi Hetilap, vol. 157, no. 13, pp. 483-487. https://doi.org/10.1556/650.2016.30396
Balázs N, Péter K, Ádám N, Zsófia L, Attila C, István K et al. Aszimmetrikus dimetilarginin: A cardiovascularis betegségek prediktora? Orvosi Hetilap. 2016 Mar 1;157(13):483-487. https://doi.org/10.1556/650.2016.30396
Balázs, Németh ; Péter, Kustán ; Ádám, Németh ; Zsófia, Lenkey ; Attila, Cziráki ; István, Kiss ; Sulyok, E. ; Zénó, Ajtay. / Aszimmetrikus dimetilarginin : A cardiovascularis betegségek prediktora?. In: Orvosi Hetilap. 2016 ; Vol. 157, No. 13. pp. 483-487.
@article{0b61ad26be344656a508045ce6e50ec0,
title = "Aszimmetrikus dimetilarginin: A cardiovascularis betegs{\'e}gek prediktora?",
abstract = "Cardiovascular diseases are the most common diseases worldwide. They are responsible for one third of global deaths and they are the leading cause of disability, too. The usage of different levels of prevention in combination with effective risk assessment improved these statistical data. Risk assessment based on classic risk factors has recently been supported with several new markers, such as asymmetric dimethylarginine, which is an endogenous competitive inhibitor of nitric oxide synthase. Elevated levels of asymmetric dimethylarginine have been reported in obese, smoker, hypercholesterolemic, hypertensive and diabetic patients. According to previous studies, asymmetric dimethylarginine is a suitable indicator of endothelial dysfunction, which is held to be the previous state of atherosclerosis. Several researches found positive correlation between higher levels of asymmetric dimethylarginine and coronary artery disease onset, or progression of existing coronary disease. According to a study involving 3000 patients, asymmetric dimethylarginine is an independent risk factor of cardiovascular mortality in patients with coronary artery disease. This article summarizes the role of asymmetric dimethylarginine in prediction of cardiovascular diseases, and underlines its importance in cardiovascular prevention.",
keywords = "Asymmetric dimethylarginine, Oxidative stress, Risk stratification",
author = "N{\'e}meth Bal{\'a}zs and Kust{\'a}n P{\'e}ter and N{\'e}meth {\'A}d{\'a}m and Lenkey Zs{\'o}fia and Czir{\'a}ki Attila and Kiss Istv{\'a}n and E. Sulyok and Ajtay Z{\'e}n{\'o}",
year = "2016",
month = "3",
day = "1",
doi = "10.1556/650.2016.30396",
language = "Hungarian",
volume = "157",
pages = "483--487",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "13",

}

TY - JOUR

T1 - Aszimmetrikus dimetilarginin

T2 - A cardiovascularis betegségek prediktora?

AU - Balázs, Németh

AU - Péter, Kustán

AU - Ádám, Németh

AU - Zsófia, Lenkey

AU - Attila, Cziráki

AU - István, Kiss

AU - Sulyok, E.

AU - Zénó, Ajtay

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Cardiovascular diseases are the most common diseases worldwide. They are responsible for one third of global deaths and they are the leading cause of disability, too. The usage of different levels of prevention in combination with effective risk assessment improved these statistical data. Risk assessment based on classic risk factors has recently been supported with several new markers, such as asymmetric dimethylarginine, which is an endogenous competitive inhibitor of nitric oxide synthase. Elevated levels of asymmetric dimethylarginine have been reported in obese, smoker, hypercholesterolemic, hypertensive and diabetic patients. According to previous studies, asymmetric dimethylarginine is a suitable indicator of endothelial dysfunction, which is held to be the previous state of atherosclerosis. Several researches found positive correlation between higher levels of asymmetric dimethylarginine and coronary artery disease onset, or progression of existing coronary disease. According to a study involving 3000 patients, asymmetric dimethylarginine is an independent risk factor of cardiovascular mortality in patients with coronary artery disease. This article summarizes the role of asymmetric dimethylarginine in prediction of cardiovascular diseases, and underlines its importance in cardiovascular prevention.

AB - Cardiovascular diseases are the most common diseases worldwide. They are responsible for one third of global deaths and they are the leading cause of disability, too. The usage of different levels of prevention in combination with effective risk assessment improved these statistical data. Risk assessment based on classic risk factors has recently been supported with several new markers, such as asymmetric dimethylarginine, which is an endogenous competitive inhibitor of nitric oxide synthase. Elevated levels of asymmetric dimethylarginine have been reported in obese, smoker, hypercholesterolemic, hypertensive and diabetic patients. According to previous studies, asymmetric dimethylarginine is a suitable indicator of endothelial dysfunction, which is held to be the previous state of atherosclerosis. Several researches found positive correlation between higher levels of asymmetric dimethylarginine and coronary artery disease onset, or progression of existing coronary disease. According to a study involving 3000 patients, asymmetric dimethylarginine is an independent risk factor of cardiovascular mortality in patients with coronary artery disease. This article summarizes the role of asymmetric dimethylarginine in prediction of cardiovascular diseases, and underlines its importance in cardiovascular prevention.

KW - Asymmetric dimethylarginine

KW - Oxidative stress

KW - Risk stratification

UR - http://www.scopus.com/inward/record.url?scp=84961689600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961689600&partnerID=8YFLogxK

U2 - 10.1556/650.2016.30396

DO - 10.1556/650.2016.30396

M3 - Article

C2 - 26996894

AN - SCOPUS:84961689600

VL - 157

SP - 483

EP - 487

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 13

ER -